SCHEMBL3979538

SCHEMBL3979538

COc1ccc(C(=O)NNC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)cc1C#N

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
MAPT P10636 5/20 0.49
HPGD P15428 5/20 0.49
HTT P42858 4/20 0.49
KDM4E B2RXH2 3/20 0.49
KMT2A Q03164 3/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 4/20 0.45
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
GAA P10253 2/20 0.41
ALOX12 P18054 1/20 0.41
GRM5 P41594 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977139 0.88 ALDH1A1 (0.43) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3982962 0.88 KDM4E (0.39) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3976676 0.88 ELANE (0.40) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3974631 0.87 CTSA (0.47) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3978634 0.87 CYP3A4 (0.56) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3979482 0.85 KMT2A (0.46) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3975924 0.85 GRM5 (0.41) KDM4EKMT2AMEN1LMNAGRM5
SCHEMBL3976996 0.84 L3MBTL1 (0.51) ALDH1A1MAPTHPGDKDM4EKMT2A
SCHEMBL3978024 0.84 CYP3A4 (0.45) ALDH1A1MAPTHPGDHTTKDM4E
SCHEMBL3982336 0.84 LMNA (0.47) ALDH1A1MAPTHPGDHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALDH1A1 1389/4885MAPT 4833/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.